本刊編輯部
2021年5月22日,被譽(yù)為“中國肝膽外科之父”的吳孟超院士逝世,享年99歲。這位90多歲高齡仍堅(jiān)持不下手術(shù)臺(tái)的老先生,說過一句話:“名譽(yù)算什么?我不過就是一個(gè)吳孟超嘛。”他一生,這樣默默奉獻(xiàn),為國家、為醫(yī)學(xué)、為病人付出一切。但誰能不承認(rèn)他就是夜空中熠熠生輝的一顆明星呢?
Wu Mengchao, founder of 1)hepatobiliary surgery in China and teacher of 2)roughly 80 percent of the experts and doctors specializing in 3)liver surgeries in the country today, died at age 99 in Shanghai on May 22.
Wu Mengchao was born in Minqing County, Fujian Province in 1922, and went to Malaysia with his family as a child. Later, he returned to China alone and was admitted to the School of Medicine of Shanghai-based Tongji University (now as Tongji Medical College of Huazhong University of Science and Technology). After graduating in 1949, Wu Mengchao became a 4)surgeon of the first hospital 5)affiliated with the Second Military Medical University in Shanghai.
In 1956, he joined the Communist Party of China as well as the People's Liberation Army (PLA) and completed the first liver 6)tumor 7)resection in China in 1960.
1) hepatobiliary [hep?t???b?lj?r?] adj.肝膽的
2) roughly [?r?fli] adv.大體上
3) liver [?l?v?(r)] n.肝臟
4) surgeon [?s??d??n] n.外科醫(yī)生
5) affiliate [??f?lie?t] v.附屬
6) tumor [tju?m?(r)] n.腫瘤
7) resection [r??sek?n] n.(外科)切除術(shù)
In more than 75 years, Wu Mengchao led the team to successfully complete the world's first middle hepatic lobectomy, and successfully remove the world's largest hepatic cavernous hemangioma, which was the youngest patient in the world. The success rate of liver cancer surgery in China has increased from 15% in the early 1960s to 98.5%, and the overall 5-year survival rate of patients undergoing liver cancer resection is close to 50%.
In 2006, Wu Mengchao won the 2005 National Highest Science and
Technology Award. He 8)resolutely donated RMB 6 million in prize money, and joined 6 well-known academicians to 9)submit to the State Council a proposal for “integrated research on the pathogenesis and prevention of hepatitis B liver cancer”, which was included in a major national science and technology project.
Long before that, in 1997, Wu already set up a fund with a total of 5 million yuan bonus and social donations that he received to reward experts with outstanding achievements in the field of hepatobiliary surgery in China.
8) resolutely [?r?z?lu?tli] adv.堅(jiān)決地
9) submit [s?b?m?t] v.提交
Today, the National Liver Cancer Science Center has stood in Anting, Shanghai, and has become the world's largest liver cancer research and prevention base.
Promoting Chinese liver medicine from acratch, from being to being 10)refined, Wu Mengchao's achievements have attracted the attention and admiration of colleagues around the world.
“A person's life is limited, and you will pass without a hurry. Therefore, I must hurry up and fight every second to do more for the country and the people.” Wu Mengchao once said.
Now, Wu Mengchao can finally have a rest, but “Wu Mengchao” star, which the international community named the 11)asteroid 17606, is still shining brightly in the sky.
10) refine [r??fa?n] v.改善
11) asteroid [??st?r??d] n.小行星
詞組加油站
specialize in專門研究
from scratch從零開始
吳孟超,中國肝膽外科的創(chuàng)始人,也是現(xiàn)今中國肝臟外科學(xué)方面80%的專家、醫(yī)生的老師,于5月22日在上海逝世,享年99歲。
吳孟超,1922年出生于福建省閩清縣,幼時(shí)隨家人前往馬來西亞。后來,他獨(dú)自一人回國,考入同濟(jì)大學(xué)醫(yī)學(xué)院(今華中科技大學(xué)同濟(jì)醫(yī)學(xué)院)。1949年畢業(yè),吳孟超進(jìn)入上海第二軍醫(yī)大學(xué)第一附屬醫(yī)院,成為一名外科醫(yī)生。
1956年,吳孟超加入中國共產(chǎn)黨并參軍入伍,并于1960年成功完成中國第一例肝癌切除手術(shù)。
在超過75年的工作時(shí)間里,吳孟超領(lǐng)導(dǎo)團(tuán)隊(duì)成功完成了世界上第一臺(tái)人體中肝葉切除手術(shù),成功從世界最年幼的病人身上切除了世界最大的肝海綿狀血管瘤。中國肝癌手術(shù)成功率從20世紀(jì)60年代初的15%上升到現(xiàn)在的98.5%,肝癌切除手術(shù)病人術(shù)后五年總存活率接近50%。
2006年,吳孟超榮獲2005年度國家最高科學(xué)技術(shù)獎(jiǎng)。他毅然捐出了600萬元的獎(jiǎng)金,又聯(lián)合6位知名院士向國務(wù)院提交了“集成式研究乙型肝炎肝癌的發(fā)病機(jī)理與防治”的建議案,該建議案被列入國家科技重大專項(xiàng)。
早在1997年,吳孟超就用其所獲獎(jiǎng)金和社會(huì)捐贈(zèng)共500萬元成立了一項(xiàng)基金,用于獎(jiǎng)勵(lì)中國肝膽外科的杰出人才。
如今,國家肝癌科學(xué)中心已屹立在上海安亭,成為世界最大的肝癌研究和防治基地。
推動(dòng)中國肝臟醫(yī)學(xué)從無到有,從有到精,吳孟超的成就令全球同行矚目、敬佩。
“一個(gè)人生命有限,你不抓緊一下就過去了,所以我要抓緊時(shí)間,分秒必爭,為國家、為人民多干點(diǎn)事?!眳敲铣f。
如今,吳老終于可以好好休息了,但國際社會(huì)命名為“吳孟超”星的17606號(hào)小行星,仍在天幕中熠熠生輝。